الشرائح

الأهداف

Abbr.

1 Assess appropriateness of drug therapy for endotra-

2.

Assess appropriateness of drug therapy for endotra-

AC/VC

Assist control/volume control

NMBA

Neuromuscular blocking agent

A.

Acute lung injury.

B.

Moderate to severe.

C.

Mild to moderate.

D.

Mild.

2.

Several clinical trials have been conducted in mod-

A.

100–200 mm Hg.

B.

Greater than 150 mm Hg.

C.

Less than 150 mm Hg.

D.

50–150 mm Hg.

A.

6 mL/kg of total body weight.

B.

4 mL/kg of ideal body weight.

C.

7 mL/kg of total body weight.

🫧 Pulmonary Disorders I

29

PDF Pages

1+

Objectives

0

Slides

0:00

Duration

0:00 / 0:00

جارٍ توليد الفيديو...

الوحدة السابقة

Pain, Agitation/Sedation, Delirium, Immobility & Sleep

الوحدة التالية

Pulmonary Disorders II